Guardant Health
GH
#1121
Rank
HK$163.97 B
Marketcap
HK$1,212
Share price
-0.17%
Change (1 day)
59.62%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Market capitalization of Guardant Health (GH)

Market cap: HK$163.97 Billion

As of November 2026 Guardant Health has a market cap of HK$163.97 Billion. This makes Guardant Health the world's 1121th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Guardant Health from 2018 to 2026

End of year Market Cap

Year Marketcap Change
2026HK$163.97 B57.58%
2025HK$104.06 B256.39%
2024HK$29.19 B13.87%
2023HK$25.64 B17.79%
2022HK$21.76 B-72.54%
2021HK$79.28 B-20.62%
2020HK$99.88 B74.78%
2019HK$57.14 B126.39%
2018HK$25.24 B

End of Day market cap according to different sources

On Nov 11th, 2026 the market cap of Guardant Health was reported to be:

HK$164.25 Billion
by Nasdaq info icon info icon
HK$164.25 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Neogen
NEOG
HK$19.63 B-88.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
HK$357.92 B 118.28%๐Ÿ‡บ๐Ÿ‡ธ USA